Found: 14
Select item for more details and to access through your institution.
Once‐weekly semaglutide use in patients with type 2 diabetes: Real‐world data from the SURE Italy observational study.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1658, doi. 10.1111/dom.15020
- By:
- Publication type:
- Article
Make your diabetic patients walk: long-term impact of different amounts of physical activity on type 2 diabetes.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Make Your Diabetic Patients Walk.
- Published in:
- Diabetes Care, 2005, v. 28, n. 6, p. 1295, doi. 10.2337/diacare.28.6.1295
- By:
- Publication type:
- Article
Validation of a Counseling Strategy to Promote the Adoption and the Maintenance of Physical Activity by Type 2 Diabetic Subjects.
- Published in:
- Diabetes Care, 2003, v. 26, n. 2, p. 404, doi. 10.2337/diacare.26.2.404
- By:
- Publication type:
- Article
Contribution of Postprandial Versus Interprandial Blood Glucose to HbA[sub 1c] in Type 1 Diabetes on Physiologic Intensive Therapy With Lispro Insulin at Mealtime.
- Published in:
- Diabetes Care, 1999, v. 22, n. 5, p. 795, doi. 10.2337/diacare.22.5.795
- By:
- Publication type:
- Article
Insulin is required for prandial ghrelin suppression in humans.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Ghrelin is not necessary for adequate hormonal counterregulation of insulin-induced hypoglycemia.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Suitability and Usefulness of a Flexible Dosing Timing of Oral Semaglutide to Maximize Benefit in Clinical Practice: An Expert Panel.
- Published in:
- Diabetes Therapy, 2024, v. 15, n. 9, p. 1963, doi. 10.1007/s13300-024-01625-3
- By:
- Publication type:
- Article
Effectiveness, Simplification and Persistence of IDegLira in Poorly Controlled People with Type 2 Diabetes: A 4-Year Follow-Up Real-World Study.
- Published in:
- Diabetes Therapy, 2024, v. 15, n. 6, p. 1313, doi. 10.1007/s13300-024-01564-z
- By:
- Publication type:
- Article
Correction to: Effectiveness in Real World of Once Weekly Semaglutide in People with Type 2 Diabetes: Glucagon-Like Peptide Receptor Agonist Naïve or Switchers from Other Glucagon-Like Peptide Receptor Agonists: Results from a Retrospective Observational Study in Umbria
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Effectiveness in Real World of Once Weekly Semaglutide in People with Type 2 Diabetes: Glucagon-Like Peptide Receptor Agonist Naïve or Switchers from Other Glucagon-Like Peptide Receptor Agonists: Results from a Retrospective Observational Study in Umbria
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 3, p. 551, doi. 10.1007/s13300-022-01218-y
- By:
- Publication type:
- Article
Switching Patients with Type 1 Diabetes to Insulin Degludec from Other Basal Insulins: Real-World Data of Effectiveness and Safety.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 1, p. 97, doi. 10.1007/s13300-019-00722-y
- By:
- Publication type:
- Article
Impact of Insulin Degludec in Type 2 Diabetes: Real-World Data on Effectiveness and Safety.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 6, p. 2209, doi. 10.1007/s13300-018-0511-4
- By:
- Publication type:
- Article
Enhancing diabetes therapy adherence: a comprehensive study on glucometer usability for type 2 diabetes patients.
- Published in:
- Frontiers in Clinical Diabetes & Healthcare, 2024, p. 1, doi. 10.3389/fcdhc.2024.1328181
- By:
- Publication type:
- Article